GENIL.E — Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Market Cap
TRY49.66bn
Enterprise Value
TRY50.65bn
Revenue
TRY19.18bn

Annual income statement for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	R2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,501	10,639	11,769	19,294	19,181
Cost of Revenue
Gross Profit	456	1,911	2,598	3,729	4,022
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,299	9,585	11,120	17,937	17,302
Operating Profit	203	1,055	650	1,357	1,879
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	301	501	379	551	1,486
Provision for Income Taxes
Net Income After Taxes	310	641	653	188	806
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	311	640	656	195	814
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	311	640	656	195	814
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.069	0.142	0.152	0.048	0.153
Dividends per Share